SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-002359
Filing Date
2024-04-15
Accepted
2024-04-12 18:37:47
Documents
33
Period of Report
2024-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm   iXBRL 8-K 28810
2 INVESTOR PRESENTATION cns_ex9901.htm EX-99.1 29149
6 GRAPHIC image_020.jpg GRAPHIC 142059
7 GRAPHIC image_021.jpg GRAPHIC 234448
8 GRAPHIC image_022.jpg GRAPHIC 176545
9 GRAPHIC image_023.jpg GRAPHIC 120183
10 GRAPHIC image_024.jpg GRAPHIC 166017
11 GRAPHIC image_025.jpg GRAPHIC 181351
12 GRAPHIC image_027.jpg GRAPHIC 159893
13 GRAPHIC image_028.jpg GRAPHIC 174445
14 GRAPHIC image_029.jpg GRAPHIC 139150
15 GRAPHIC image_030.jpg GRAPHIC 173506
16 GRAPHIC image_031.jpg GRAPHIC 161805
17 GRAPHIC image_032.jpg GRAPHIC 241130
18 GRAPHIC image_033.jpg GRAPHIC 199608
19 GRAPHIC image_034.jpg GRAPHIC 240353
20 GRAPHIC image_035.jpg GRAPHIC 168775
21 GRAPHIC image_036.jpg GRAPHIC 176272
22 GRAPHIC image_037.jpg GRAPHIC 120155
23 GRAPHIC image_038.jpg GRAPHIC 113727
24 GRAPHIC image_040.jpg GRAPHIC 123284
  Complete submission text file 0001683168-24-002359.txt   4669362

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cnsp-20240409.xsd EX-101.SCH 3018
4 XBRL LABEL FILE cnsp-20240409_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cnsp-20240409_pre.xml EX-101.PRE 22361
36 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3802
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 24842732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)